Synnovation Therapeutics

About:

Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.

Website: https://www.synnovationtx.com

Top Investors: Cormorant Asset Management, Third Rock Ventures, Lilly Asia Ventures, Nextech Invest, Sirona Capital

Description:

Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers. It is dedicated to the discovery and development of therapeutics that can improve the lives of people with cancer. Leveraging its deep expertise in medicinal chemistry, cancer biology, and patient-focused precision medicine, it builds a diverse pipeline of novel small-molecule targeted therapies. It aims to efficiently advance these agents into clinical trials with the goal of transforming cancer patient care.

Total Funding Amount:

$139M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Wilmington, Delaware, United States

Founded Date:

2021-01-01

Contact Email:

contact(AT)synnovationtx.com

Founders:

Wenqing Yao

Number of Employees:

11-50

Last Funding Date:

2023-12-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai